Open access
Jul 2026
Profiling fungal secondary metabolites with anti-leishmanial activity: an integrated in silico and in vitro study.
Dihydrocitrinone's promising antileishmanial potency provides a suitable scaffold for medicinal chemistry optimization and the development of novel therapeutics for leishmaniasis and highlights the underexplored potential of fungal SMs in antileishmanial drug discovery.
Parastoo Hassani-Abharian, M. Ghanadian, A. Fassihi et al.
· Scientific Reports · 0 citations